$RTX

Raytheon snaps up $6.3 billion deal for SM-3 IB interceptors

Raytheon, an RTX business, secured a $6.3B contract for SM-3 IB interceptors, spanning five years with two optional years. The deal supports missile defense inventory replenishment and is part of recent agreements with the Department of War. Production will occur at facilities in Tucson, Arizona, and Huntsville, Alabama. Raytheon's Phil Jasper highlighted the company's commitment to increasing munitions production.

Original reporting
Published Oct 9, 2026, 7:40 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 9, 2026, 10:09 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Raytheon snaps up $6.3 billion deal for SM-3 IB interceptors — source image
Decision brief

The 30-second read

$RTXBullishHigh
01

Why it matters

The $6.3 billion award expands RTX's defense backlog and may lift earnings forecasts for the fiscal year.

02

Market read

First disclosure of a multi‑billion defense contract; likely to move RTX stock higher in the short term.

03

What to watch

Potential cost overruns or future budget cuts for the Navy could offset the positive impact.

Relevance 7/10Novelty 9/10Timing: pre‑market today

Background

Raytheon, operating under the RTX umbrella, is a major U.S. defense contractor. The SM‑3 IB interceptor is part of the Navy's integrated missile‑defense architecture.

Company-level read

Ticker impact

$RTXBullishHigh confidence
Context

Raytheon (RTX) secured a five‑year, up‑to‑$6.3 billion contract to produce SM‑3 IB interceptors.

Expected impact

likely upward pressure as investors price in the new contract revenue

Evidence & confidence

Large, newly disclosed defense contract; market typically reacts positively to defense wins.

Market effects

Boosts defense and aerospace sector sentiment, especially missile‑defense suppliers.

U.S. defense stocks may see modest gains.

Reinforces confidence in U.S. defense procurement amid global security concerns.

Counterpoint

If the contract faces execution delays, the upside could be muted.

Key entities

  • Raytheon

    Defense contractor, subsidiary of RTX.

  • U.S. Navy

    Primary customer for the SM‑3 IB interceptors.

Related articles

$RTXMed

$6.3 billion Pentagon deal buys more interceptors to shoot down ballistic missiles

Raytheon, an RTX business, received a $6.3 billion Pentagon contract for Standard Missile-3 Block IB interceptors. The deal includes $454 million in immediate funds for fiscal year 2026. Production will occur in Tucson, Arizona, and Huntsville, Alabama, supporting domestic defense vendors. The interceptors can be deployed from ship or land to defend against short- to intermediate-range ballistic missiles.

$RTXMed

RTX Keeps Winning Contracts, but Jim Cramer Sees a Complication

RTX Corporation (NYSE:RTX) reported Q2 sales of $24.7B, up 14%, and adjusted EPS of $1.89, up 21%. Its backlog reached $289B. Management raised its full-year adjusted EPS outlook to $7.10-$7.25. RTX secured a $20.7B missile production contract. Jim Cramer noted defense demand but concerns about commercial aviation and engine-related costs.

$RTXMed

RTX Initiates Coverage On Barclays -- Rating Set to Overweight

Barclays initiated coverage on RTX (Raytheon Technologies) with an 'Overweight' rating and a $223.00 price target. RTX is currently trading at $183.58, which is 18.2% overvalued according to its GF Value™ of $155.33. The company has a GF Score™ of 88/100, indicating strong overall performance. Insider activity shows significant selling, with $6.86 million in sales over the past three months.